Operator
Ladies and gentlemen, thank you for standing by, and welcome to G1 Therapeutics Fourth Quarter 2020 Financial Results Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker host today, Will Roberts, Head of Investor actions at G1 Therapeutics. Please go ahead.
William Roberts
Vice President, Investor Relations and Corporate Communications
Thank you, Lydia. Good afternoon, everybody, and welcome to the G1 conference call to discuss our fourth quarter and full year 2020 financial results and business update. The press release on these financial results was issued after market closed this afternoon and can be found in our news section of our corporate website, g1therapeutics.com. On this afternoon s call, the team will provide an overview of the fourth quarter and full year 2020, including an update on our launch progress with COSELA, which was approved by the U.S. Food and Drug Administration on February 12, 2021, to decre